A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.

A new blood test will be offered to lung cancer patients in a move that NHS England says will benefit about 15,000 people each year. The test, known as a liquid biopsy, is designed to speed up access ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Patients with suspected lung cancer could be diagnosed or have the disease ruled out faster under a new NHS pilot that combines artificial intelligence (AI) with robotic technology. Officials hailed ...

The MarketWatch News Department was not involved in the creation of this content. OXFORD, United Kingdom and HOUSTON, Jan. 29, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer risk ...